Gallid herpesvirus 3 (ATCC® VR-2176)

Classification: Herpesviridae, Mardivirus  /  Product Format: frozen

Classification Herpesviridae, Mardivirus
Deposited As Marek's disease virus type 2
Agent Gallid herpesvirus 3
Strain 301B/1
Applications
Must be preserved in living cells to maintain viability (10% DMSO).
Must be preserved in living cells to maintain viability (10% DMSO).
Biosafety Level 2
Product Format frozen
Storage Conditions -196C
Comments
Must be preserved in living cells to maintain viability (10% DMSO). Vaccine strain.
Effect on Host
Cytopathic effects in tissue culture
Recommended Host
primary and secondary chicken embryo fibroblasts
Growth Conditions
Incubation: 3 days
Effect on Host
Cytopathic effects in tissue culture
Name of Depositor RL Witter
References

Witter RL. Serotype 2 Marek's disease vaccine. US Patent 4,895,718 dated Jan 23 1990